Hereditary Angioedema (HAE) in China: Advancing Awareness, Access, Advocacy and Alliances From the Greater Bay Area to the Global HAE Community
- PMID: 40038863
- PMCID: PMC12325137
- DOI: 10.1111/cea.70014
Hereditary Angioedema (HAE) in China: Advancing Awareness, Access, Advocacy and Alliances From the Greater Bay Area to the Global HAE Community
Abstract
The article offers an overview of the progress in managing Hereditary Angioedema (HAE) in China, with a specific focus on the Greater Bay Area (GBA). Through the '4As' framework-Awareness, Access, Advocacy and Alliance-the article explores the challenges and advancements in HAE care. In terms of collaborative initiatives such as the HAE-ASIA (Angioedema Screening In Asia) collaboration and the GBA HAE Alliance "Hub-and-Spoke model" aim to bridge the gap between East and West, providing optimal patient care and advancing HAE management. By bridging the gap between East and West, the GBA aims to deliver optimal patient care and advance HAE management. Moving forward, it will be essential to persist in nurturing national and international collaborations, not only within China but also extending beyond its borders. These partnerships encourage the exchange of knowledge, research, and best practices, all of which are critical in propelling forward the care of HAE. By uniting as a worldwide community, we can significantly advance efforts to improve the quality of life for those affected by HAE across the globe.
Keywords: China; Greater Bay Area; access; advocacy; alliance; angioedema; awareness; hereditary.
© 2025 The Author(s). Clinical & Experimental Allergy published by John Wiley & Sons Ltd.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures




References
-
- Busse P. J. and Christiansen S. C., “Hereditary Angioedema,” New England Journal of Medicine 382 (2020): 1136–1148. - PubMed
-
- Maurer M., Magerl M., Betschel S., et al., “The International WAO/EAACI Guideline for the Management of Hereditary Angioedema‐The 2021 Revision and Update,” Allergy 77 (2022): 1961–1990. - PubMed
-
- Zuberbier T., Abdul Latiff A. H., Abuzakouk M., et al., “The International EAACI/GA(2)LEN/EuroGuiDerm/APAAACI Guideline for the Definition, Classification, Diagnosis, and Management of Urticaria,” Allergy 77 (2022): 734–766. - PubMed
-
- Reshef A., Buttgereit T., Betschel S. D., et al., “Definition, Acronyms, Nomenclature, and Classification of Angioedema (DANCE): AAAAI, ACAAI, ACARE, and APAAACI DANCE Consensus,” Journal of Allergy and Clinical Immunology 154 (2024): 398–411. - PubMed
-
- Bock S. C., Skriver K., Nielsen E., et al., “Human C1 Inhibitor: Primary Structure, cDNA Cloning, and Chromosomal Localization,” Biochemistry 25 (1986): 4292–4301. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous